{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T17:57:27Z","timestamp":1792259847505,"version":"4.4.0"},"reference-count":15,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,3]],"date-time":"2025-09-03T00:00:00Z","timestamp":1756857600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ctro.science","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical and Translational Radiation Oncology"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.ctro.2025.101043","type":"journal-article","created":{"date-parts":[[2025,9,5]],"date-time":"2025-09-05T00:22:52Z","timestamp":1757031772000},"page":"101043","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Patterns of prostate recurrence after focal salvage prostate brachytherapy for radiorecurrent prostate cancer"],"prefix":"10.1016","volume":"56","author":[{"given":"Alba Dom\u00ednguez","family":"Dom\u00ednguez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3493-4808","authenticated-orcid":false,"given":"Niels den","family":"Haan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-9492-4838","authenticated-orcid":false,"given":"Jan","family":"Wiersma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josephina C.C.","family":"Koppes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karel A.","family":"Hinnen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7427-8836","authenticated-orcid":false,"given":"Bradley R.","family":"Pieters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ctro.2025.101043_b0005","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.eururo.2020.11.010","article-title":"A systematic review and meta-analysis of local salvage therapies after radiotherapy for prostate cancer (MASTER)","volume":"80","author":"Valle","year":"2021","journal-title":"Eur Urol"},{"key":"10.1016\/j.ctro.2025.101043_b0010","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.clon.2019.10.008","article-title":"Single-dose focal salvage high dose rate brachytherapy for locally recurrent prostate cancer","volume":"32","author":"Chitmanee","year":"2020","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"10.1016\/j.ctro.2025.101043_b0015","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/j.ijrobp.2018.06.039","article-title":"Focal salvage high dose-rate brachytherapy for locally recurrent prostate cancer after primary radiation therapy failure: results from a prospective clinical trial","volume":"102","author":"Murgic","year":"2018","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ctro.2025.101043_b0020","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/j.radonc.2018.07.019","article-title":"MRI guided focal HDR brachytherapy for localized prostate cancer: Toxicity, biochemical outcome and quality of life","volume":"129","author":"Maenhout","year":"2018","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ctro.2025.101043_b0025","first-page":"20","article-title":"Efficacy and toxicity outcomes for patients treated with focal salvage high dose rate brachytherapy for locally recurrent prostate cancer","volume":"23","author":"Slevin","year":"2020","journal-title":"Clin Transl Radiat Oncol"},{"key":"10.1016\/j.ctro.2025.101043_b0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.prro.2022.05.018","article-title":"A prospective study of magnetic resonance imaging-guided focal salvage high-dose-rate brachytherapy for radiorecurrent prostate cancer: updated results of 30 patients","volume":"12","author":"Corkum","year":"2022","journal-title":"Pract Radiat Oncol"},{"key":"10.1016\/j.ctro.2025.101043_b0035","first-page":"1","article-title":"Determining the safety of ultrafocal salvage high-dose-rate brachytherapy for radiorecurrent prostate cancer: a toxicity assessment of 150 patients","volume":"27","author":"van Son","year":"2021","journal-title":"Clin Transl Radiat Oncol"},{"key":"10.1016\/j.ctro.2025.101043_b0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijrobp.2025.02.042","article-title":"The importance of multi-parametric MRI, PET\/CT, and biopsy for identifying and delineating the extent of intraprostatic radiorecurrent prostate cancer: a secondary analysis of the F-SHARP clinical trial","author":"Venkatesulu","year":"2025","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ctro.2025.101043_b0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.radonc.2023.109495","article-title":"Recurrence characteristics after focal salvage HDR brachytherapy in prostate cancer","volume":"180","author":"Rasing","year":"2023","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ctro.2025.101043_b0050","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.radonc.2015.10.021","article-title":"A Delphi consensus study on salvage brachytherapy for prostate cancer relapse after radiotherapy, a Uro-GEC study","volume":"118","author":"Kaljouw","year":"2016","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ctro.2025.101043_b0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.radonc.2023.109672","article-title":"Salvage prostate brachytherapy in radiorecurrent prostate cancer: an international Delphi consensus study","volume":"184","author":"Corkum","year":"2023","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ctro.2025.101043_b0060","doi-asserted-by":"crossref","first-page":"26","DOI":"10.21037\/cco-23-4","article-title":"Focal versus whole gland salvage brachytherapy for recurrent prostate cancer in the prostate specific membrane antigen PET era: a narrative review","volume":"12","author":"Andring","year":"2023","journal-title":"Chin Clin Oncol"},{"key":"10.1016\/j.ctro.2025.101043_b0065","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1007\/s00066-024-02205-x","article-title":"Evaluation of the safety and efficacy of high-dose rate brachytherapy for radiorecurrent prostate cancer: a systematic review and meta-analysis","volume":"200","author":"Shen","year":"2024","journal-title":"Strahlenther Onkol"},{"key":"10.1016\/j.ctro.2025.101043_b0070","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.ijrobp.2019.11.001","article-title":"A prospective study of 18F-DCFPyL PSMA PET\/CT restaging in recurrent prostate cancer following primary external beam radiotherapy or brachytherapy","volume":"106","author":"Liu","year":"2020","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ctro.2025.101043_b0075","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.eururo.2019.01.049","volume":"77","author":"Perera","year":"2020","journal-title":"Eur Urol"}],"container-title":["Clinical and Translational Radiation Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405630825001351?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405630825001351?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T07:35:11Z","timestamp":1787729711000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405630825001351"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":15,"alternative-id":["S2405630825001351"],"URL":"https:\/\/doi.org\/10.1016\/j.ctro.2025.101043","relation":{},"ISSN":["2405-6308"],"issn-type":[{"value":"2405-6308","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Patterns of prostate recurrence after focal salvage prostate brachytherapy for radiorecurrent prostate cancer","name":"articletitle","label":"Article Title"},{"value":"Clinical and Translational Radiation Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ctro.2025.101043","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier B.V. on behalf of European Society for Radiotherapy and Oncology.","name":"copyright","label":"Copyright"}],"article-number":"101043"}}